| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/22/2002 | WO2002064792A2 Molecules for disease detection and treatment |
| 08/22/2002 | WO2002064791A2 Proteins and nucleic acids encoding same |
| 08/22/2002 | WO2002064790A2 Jfy1 protein induces rapid apoptosis |
| 08/22/2002 | WO2002064789A1 Protein-coupled receptor |
| 08/22/2002 | WO2002064788A2 Compositions and methods relating to lung specific genes and proteins |
| 08/22/2002 | WO2002064787A1 Neurotonin and use thereof |
| 08/22/2002 | WO2002064786A1 Novel gene tcif |
| 08/22/2002 | WO2002064785A1 NOVEL CLOCK GENE Bmal2 |
| 08/22/2002 | WO2002064784A2 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 08/22/2002 | WO2002064783A2 Novel cofactors of the estrogen receptor beta and methods of use |
| 08/22/2002 | WO2002064782A2 Rank ligand-binding polypeptides |
| 08/22/2002 | WO2002064781A2 Regulation of amyloid precursor protein expression by modification of abc transporter expression or activity |
| 08/22/2002 | WO2002064780A1 Dna sequences for human tumour suppressor genes |
| 08/22/2002 | WO2002064778A1 Rna showing neuron survival activity |
| 08/22/2002 | WO2002064776A2 Signal transduction proteins 15b3, 15b3-1 and 15b3-2, and related dna sequences |
| 08/22/2002 | WO2002064775A1 Identification of genes involved in the tumourigenic process |
| 08/22/2002 | WO2002064774A2 Orientation-directed construction of plasmids |
| 08/22/2002 | WO2002064773A2 Method for high throughput screening of candidate compounds by high throughput direct synthesis of recombinant polypeptides |
| 08/22/2002 | WO2002064771A1 Novel cell adhesion molecule specific to activated leukocyte |
| 08/22/2002 | WO2002064767A1 Method of transferring selected molecules |
| 08/22/2002 | WO2002064766A2 Bax-responsive genes for drug target identification in yeast and fungi |
| 08/22/2002 | WO2002064764A2 Terpene synthase/cyclase and olefin synthase and uses thereof |
| 08/22/2002 | WO2002064763A1 Novel human poly(a)polymerase gamma (pap gamma) |
| 08/22/2002 | WO2002064761A2 Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein |
| 08/22/2002 | WO2002064760A2 Expression of recombinant proteinase k from tritirachium album in yeast |
| 08/22/2002 | WO2002064758A1 An optical method for testing sensitivity of cells |
| 08/22/2002 | WO2002064757A2 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/22/2002 | WO2002064755A2 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | WO2002064752A1 Method for the production of nucleic acids |
| 08/22/2002 | WO2002064750A2 Expression system for seed proteins |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064747A2 Fusion proteins based upon somatostatin receptors |
| 08/22/2002 | WO2002064746A2 Combined transductional and transcriptional targeting system for improved gene delivery |
| 08/22/2002 | WO2002064745A2 Transformation and regeneration of sunflower from cotyledons |
| 08/22/2002 | WO2002064737A2 Antisense modulation of protein phosphatase 2 catalytic subunit beta expression |
| 08/22/2002 | WO2002064731A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/22/2002 | WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 08/22/2002 | WO2002064631A2 T1r taste receptors and genes encoding same |
| 08/22/2002 | WO2002064630A2 Il-1 receptor accessory protein |
| 08/22/2002 | WO2002064629A2 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof |
| 08/22/2002 | WO2002064628A2 Isolated human transporter proteins nucleic acids and use thereof |
| 08/22/2002 | WO2002064626A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 08/22/2002 | WO2002064625A1 Matrix gene expression in chondrogenesis |
| 08/22/2002 | WO2002064624A2 Improved method for production of secreted proteins in fungi |
| 08/22/2002 | WO2002064622A1 Method for purifying the helicobacter adhesin-like protein a (alpa) |
| 08/22/2002 | WO2002064621A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent |
| 08/22/2002 | WO2002064615A2 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 08/22/2002 | WO2002064612A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | WO2002064610A1 Polynucleotide constructs for increased lysine production |
| 08/22/2002 | WO2002064172A2 Fhit gene therapy prevents tumor development in fhit-deficient mice |
| 08/22/2002 | WO2002064171A1 Adenoviral transduction of fragile histidine triad (fhit) into cancer cells |
| 08/22/2002 | WO2002064164A1 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same |
| 08/22/2002 | WO2002064161A2 Method and compositions for immunization with the pseudomonas v antigen |
| 08/22/2002 | WO2002064159A1 Remedies for tumor in hematopoietic organs |
| 08/22/2002 | WO2002064157A2 Localized myocardial injection method for treating ischemic myocardium |
| 08/22/2002 | WO2002064092A2 Method for evaluating therapeutic efficacy |
| 08/22/2002 | WO2002064015A2 Pin1 as a marker for prostate cancer |
| 08/22/2002 | WO2002063975A2 Feed additive compositions and methods |
| 08/22/2002 | WO2002063951A2 Human disease modeling using somatic gene transfer |
| 08/22/2002 | WO2002053583A3 Amphipathic peptides and their use for transferring substances of interest into cells |
| 08/22/2002 | WO2002047534A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2002044361A3 Eukaryotic expression libraries based on double lox recombination and methods of use |
| 08/22/2002 | WO2002044325A3 Antisense modulation of src-1 expression |
| 08/22/2002 | WO2002043658A3 Fcrn-based therapeutics for the treatment of auto-immune disorders |
| 08/22/2002 | WO2002026107A3 Model for neurodegenerative diseases involving amyloid accumulation |
| 08/22/2002 | WO2002024221A3 Notch receptor agonists and uses |
| 08/22/2002 | WO2002018604A3 Methods and compositions for determining isomerase enzymatic activity |
| 08/22/2002 | WO2002018559A3 50566, human glyoxalase ii related factor and uses thereof |
| 08/22/2002 | WO2002015939A3 Calycins |
| 08/22/2002 | WO2002014508A3 Arrayed collection of genomic clones |
| 08/22/2002 | WO2002010394A3 Nucleic acids, by means of which plants with altered metabolite content can be produced |
| 08/22/2002 | WO2002002773A3 Dual specificity antibodies and methods of making and using |
| 08/22/2002 | WO2002002602A3 Slgp protein and nucleic acid molecules and uses therefor |
| 08/22/2002 | WO2002000689A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR11, AND USES THEREOF |
| 08/22/2002 | WO2002000001A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR20, AND USES THEREOF |
| 08/22/2002 | WO2001096541A3 Allosterically regulated ribozymes |
| 08/22/2002 | WO2001088090A3 Cng3b: a novel cyclic nucleotide-gated cation channel |
| 08/22/2002 | WO2001083737A3 Porcine adenovirus type 5 vector and vaccine |
| 08/22/2002 | WO2001083553A3 G protein-coupled receptors |
| 08/22/2002 | WO2001081557A3 Human kinase proteins and polynucleotides encoding the same |
| 08/22/2002 | WO2001079477A3 Identification, isolation and use of a wheat storage protein gene variant |
| 08/22/2002 | WO2001075143A3 Sigma binding region of rna polymerase and uses thereof |
| 08/22/2002 | WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof |
| 08/22/2002 | WO2001072775A3 Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer |
| 08/22/2002 | WO2001072295A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2001070982A3 Brca-1 regulators and methods of use |
| 08/22/2002 | WO2001068887A3 Hypoallergenic transgenic soybeans |
| 08/22/2002 | WO2001060517A3 Container for nucleic acid analysis |
| 08/22/2002 | WO2001042506A9 T1 receptor-like ligand ii and uses thereof |
| 08/22/2002 | WO2000038706A9 Methods for treating cancer and for mediating chemotaxis of dendritic cells |
| 08/22/2002 | WO2000037629A9 Method of producing antihypercholesterolemic agents |
| 08/22/2002 | WO2000036092A9 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 08/22/2002 | WO2000034476A9 Nucleic acid molecules of shrimp |
| 08/22/2002 | WO2000026247A9 Ikaros isoforms and mutants |
| 08/22/2002 | WO2000024907A9 Library of novel "unnatural" natural products |
| 08/22/2002 | WO2000023465A9 Methods and reagents for isolating biologically active peptides |
| 08/22/2002 | WO2000023092A9 Contulakin-g, analogs thereof and uses therefor |
| 08/22/2002 | WO2000020449A9 MODIFIED TGF-β SUPERFAMILY PROTEINS |
| 08/22/2002 | WO2000014200A9 Essential bacterial genes and their use |
| 08/22/2002 | WO2000011195A9 C-myc is activated by beta-catenin and tcf-4 |